Follistatin 344: molecular data, studies & sources

Follistatin 344 is catalogued here as an identity or preparation requiring extra specification. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.

Compiled by PeptideTech Editors · Sources checked 2026-09-21 · Selected bibliography, not a systematic review

Molecular formula, weight & structure

Molecular record not yet resolved

Follistatin 344 is a protein precursor designation. Sequence processing and glycosylation affect the actual material; a vendor label alone does not fix its molecular weight.

MF: not assigned · MW: not assigned · Structure: not assigned

Human and clinical studies

Selected human-study records are shown with their indexed or reviewed study type. Check the original article for the intervention, formulation and controls; the molecule can also be a comparator or measured variable.

No matching human study was retained in this selected bibliography. This is a documented evidence gap in our selection, not proof that no study exists.

Preclinical research, reviews & other publications

Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.

Research publication · design requires review
Detection of black market follistatin 344.
Reichel C, Gmeiner G, Thevis M et al. · Drug testing and analysis · 2019
PMID 31758732 · DOI: 10.1002/dta.2741
Research publication · design requires review
Detection of black market follistatin 344.
Reichel C, Gmeiner G, Thevis M et al. · Drug testing and analysis · 2020
PMID 33460286 · DOI: 10.1002/dta.2882
Research publication · design requires review
Central serous chorioretinopathy associated with high-dose follistatin-344: a retrospective case series.
Dağ U, Çağlayan M, Öncül H et al. · International ophthalmology · 2020
PMID 32671599 · DOI: 10.1007/s10792-020-01501-6
Research publication · design requires review
The transgenic expression of human follistatin-344 increases skeletal muscle mass in pigs.
Chang F, Fang R, Wang M et al. · Transgenic research · 2017
PMID 27787698 · DOI: 10.1007/s11248-016-9985-x

Follistatin 344 supplier sources

Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.

Compare all Follistatin 344 sizes, forms and supplier prices →

Supplier	Recorded packages	Example source listing
Amino USAUSD	1mg Vial1 recorded offers	1mg Vial · $99.00Checked Sep 16, 2026Supplier listing
Cenexa LabsUSD	1mg Vial1 recorded offers	1mg Vial · $149.99Recorded out of stock · Checked Sep 16, 2026Supplier listing
Nuvion PeptidesCAD	1mg Vial1 recorded offers	1mg Vial · CA$149.99Recorded out of stock · Checked Sep 21, 2026Supplier listing

Reference sources & further reading

The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.

Search for additional research

These links run searches; their results have not been individually reviewed and can include unrelated compounds.

Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.